The Trump administration announced new Medicaid drug pricing agreements on August 31, 2026, with nine midsize biotechnology and pharmaceutical companies. President Trump stated in the Oval Office, surrounded by company executives, that every drug will be priced at the lowest rates available globally. Under the agreements, the companies will charge state Medicaid programs the same prices they offer to other purchasers.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
Trump administration announces Medicaid drug pricing agreements with nine companies
On August 31, 2026, the Trump administration revealed new agreements with nine biotechnology and pharmaceutical companies regarding Medicaid drug pricing. President Trump emphasized that the prices will be the lowest available worldwide.
People
President Trump
Compare the coverage
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Trump announces Medicaid drug pricing deals with 9 firms
Neutral Headline
Trump administration announces Medicaid drug pricing agreements with nine companies